As recent studies have shown that ATF1 is OE in several cancers, including hepatocellular carcinoma, non-small cell lung cancer, esophageal squamous cell carcinoma, and cervical cancer, specific inhibitors for ATF1 are being developed. This evidence concerns the gene ATF1 and cervical cancer.